| Literature DB >> 34134113 |
Huei-Ying Chen1, Joseph F Bohlen2, Brady J Maher2,3,4.
Abstract
Transcription factor 4 (TCF4, also known as ITF2 or E2-2) is a type I basic helix-loop-helix transcription factor. Autosomal dominant mutations in TCF4 cause Pitt-Hopkins syndrome (PTHS), a rare syndromic form of autism spectrum disorder. In this review, we provide an update on the progress regarding our understanding of TCF4 function at the molecular, cellular, physiological, and behavioral levels with a focus on phenotypes and therapeutic interventions. We examine upstream and downstream regulatory networks associated with TCF4 and discuss a range of in vitro and in vivo data with the aim of understanding emerging TCF4-specific mechanisms relevant for disease pathophysiology. In conclusion, we provide comments about exciting future avenues of research that may provide insights into potential new therapeutic targets for PTHS.Entities:
Keywords: Basic helix-loop-helix; Neurodevelopmental disorder; Oligodendrocyte; Pitt-Hopkins syndrome; Transcription factor 4
Mesh:
Substances:
Year: 2021 PMID: 34134113 PMCID: PMC8440355 DOI: 10.1159/000516666
Source DB: PubMed Journal: Dev Neurosci ISSN: 0378-5866 Impact factor: 3.421